KRAS status and efficacy in the first line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience. - Van Cutsem,E.; Lang,I.; D’haens,G. (J Clin Oncol, 2008)